Search Results
Bezlotoxumab More Effective in Patients with High Risk for C Diff Recurrence
Bezlotoxumab for Prevention of Clostridium difficile Infection Recurrence
Clinical Implications of Bezlotoxumab for Recurring C Diff Infections
Clostridium Difficile: The Role of Bezlotoxumab
Clostridium Difficile: The Role of Bezlotoxumab
Zinplava (bezlotoxumab)- recurrence of Clostridium difficile infection (CDI)
Factors That Impact Clostridium Difficile Infection Recurrence
11/6/2015: "Clostridium difficile: Beyond Antibiotics"
Treatment and/or Prevention or Recurrence of CDI
Clostridium Difficile Treatment: Focus on the New Guidelines -- Amanda Mercurio, PharmD.
Clostridium Difficile: Avoiding High-Risk Antibiotics
Case-Based Discussion: Treatment Considerations for IBD Patients With Recurrent C. diff Infections
